Mexico Business & Finance News

Puerto Vallarta • Riviera Nayarit • Mexico

  News &
Politics
Issues &
Opinions
Business &
Finance
Health &
Evironment
Lifestyle &
Entertainment
Travel &
Outdoors
Science &
Technology

NAFTA’s Biggest Loser: The US, After Canada and Mexico Get Rich Trading Marijuana

Luis Gomez Romero - The Conversation
go to original
May 18, 2017
Share



Trump Has No Clue What NAFTA Is (The Young Turks)

The president of the United States, Donald Trump, prides himself on his business acumen. But his protectionism may get America a truly bad deal when it comes to North America’s next big market: marijuana.

Fulfilling a campaign promise, on April 13 Canadian Prime Minister Justin Trudeau presented a bill to legalise cannabis for recreational uses (medical marijuana has been legal in the country since 2001).

Two weeks later, Mexico’s Congress followed suit, passing a bill to authorise cannabis use for medical and scientific purposes.

Two of three North American countries are now well positioned to unlock an industry that, according to Forbes magazine, was worth an estimated US$7.2 billion in 2016 and is projected to grow at a compound annual rate of 17%.

In the US, on the other hand, a protectionist administration has threatened to withdraw from the “terrible” North American Free Trade Agreement (NAFTA) and actively relaunched the US drug war. It looks like America’s businessman president may allow his country to miss out on the cannabis boom.

Prohibition is a commercial disaster

Medical marijuana research is a growth industry. Cannabinoids, a main (non-psychoactive) chemical component in marijuana, hold significant prospects for development in the pharmaceutical industry, as potentially does tetrahydrocannabinol (THC), the ingredient that makes users feel high.

Marijuana has been scientifically proven to soothe the effects of chemotherapy, treat glaucoma and ease some chronic pain. But many fields of inquiry remain untapped, thanks in large part to stringent US laws that classify cannabis as a Schedule I drug. That’s the most tightly restricted category, reserved for substances with “no currently accepted medical use.”

Pharmaceutical companies are keen to further disprove that thesis, knowing they will soon be able to patent cannabis-based medicines in both Mexico and Canada. Patients and doctors, too, have pleaded for restrictions on medical marijuana research in the US to be eased.

In the US, eight states and Washington, DC, have also legalised recreational marijuana. A total of 29 states plus the nation’s capital have legal medical cannabis.

But US Attorney General Jeff Sessions (who has declared that he “rejects the idea that America will be a better place if marijuana is sold in every corner store”) and Homeland Security chief John Kelly (who has erroneously called marijuana a “dangerous gateway drug”) consistently overlook this fact.

The Trump administration is determined to revamp prohibitionist policies. In a radical rollback of Barack Obama’s compassionate approach to nonviolent drug offenders, Sessions has actually ordered federal prosecutors to charge suspects of any drug-related crime with the “most serious, readily provable offence”, or whichever crime entails the harshest punishment.

This move will have well-documented implications for law enforcement. In 2015, marijuana arrests outweighed those made for all violent crimes combined, including murder and rape, 574,000 to 505,681, according to the NGO Human Rights Watch.

Now America’s drug war will have commercial consequences too. In the US, the National Institute on Drug Abuse has developed research mainly on the negative effects of cannabis, only marginally considering its potential medical uses.

Medical trials conducted on human beings require permission from several federal agencies, including the Department of Health and Human Services, the Food and Drug Administration, and, when it comes to illegal substances, the Drug Enforcement Agency. That makes getting clearance for cannabis trials unduly complicated.

The inconsistencies between federal and state legislation also discourage research because they do not offer a secure legal ground for patenting cannabis-based medicines. Potential investors in medical cannabis are forced to consider not only corporate competition but also criminal prosecution.

Likewise, because budding American cannabis producers struggle to access investment funding, the industry’s growth potential remains stunted.

Outsmarting Trump

If all of this sounds bad for American investors and patients, it’s good news for Mexico and Canada.

The Mexican medical marijuana bill championed by President Enrique Peña, who is not a bold politician, is quite limited. It emerged in response to the story of Grace, a profoundly epileptic eight-year-old girl for whom cannabis oil, illicitly administered by her desperate mother, proved a literal lifesaver.

By removing from cannabis the legal label of “forbidden plant”, the law will enable it to be used for medical or scientific purposes and permit the health ministry to conduct clinical research.

In legal terms, Mexican cannabis is now a commercial good that falls under NAFTA’s purview. Medical cannabis is estimated to bring in between US$1 billion and US$2 billion to Mexico over the next ten years.

Canada is making a bigger bet on marijuana. Once its cannabis-regulation bill is implemented in July 2018, it will become the second country in the world to fully legalise marijuana, after Uruguay. It will stop short of establishing an open market, though; provinces will decide where and how marijuana may be sold and priced, in conjunction with the federal government.

As in Mexico, Canadian cannabis will comprise a commercial good. Its medical marijuana market is expected to be worth US$1 billion by 2020, while recreational marijuana prospects run as high as US$22.6 billion.

Once both countries’ systems are up and running, cannabis trading between Mexico and Canada can begin. The world’s first cannabis-focused exchange traded fund has already opened on the Toronto Stock Exchange.

In theory, Canada and Mexico could also trade medical marijuana with dozens of US states. But given the current administration’s “America First” motto, anti-Mexico rhetoric and fearmongering about drugs, that may prove difficult.

The biggest losers

The federal government is also forcing the US to miss out on something more valuable than profit: improving public health and social well-being.

Drugs in general and cannabis, in particular, can do harm if misused. But they are far less dangerous than the drug war itself. After all, the health risks associated with legal cannabis can be prevented by strict packaging and labelling guidelines.

For Canada, which has long been progressive in its drug policy, cannabis legalisation should continue to reduce the harm created by the illicit drug trade.

Mexico’s bill has more radical implications for health and public safety. An average of 51 people die every day in the country’s violent drug war. That’s so many homicides that male life expectancy has actually dropped by more than half a year since 2010.

For many Mexicans, the revenue from medical marijuana is less important than the possibility of rolling back the deadly drug war. The country’s timid steps towards legalising medical marijuana have begun a critical process of democratic deliberation around using the military for law enforcement in the war on drugs.

As for the US, it needn’t miss out. If only to keep America from falling behind Canada and Mexico, a scenario that would haunt its president, Trump could take action to improve the health, wealth and safety of his people. And that, to use his own words, would actually be a “fair deal for all”.

See the original at The Conversation

Related: Trump Administration Triggers Launch of NAFTA Renegotiations (Reuters)

Related: Mexico Welcomes NAFTA Re-Negotiation, Expects Constructive Talks (The Fiscal Times)

Related: Canada’s Foreign Minister Will Visit Mexico to Discuss Renegotiating NAFTA (Fortune)

Related: NAFTA Demise Fears Fade as U.S. Firms Committed to Mexico (Reuters)

Related: Mexico Expects NAFTA Talks By Late August: Economy Minister (Reuters)

Related: Trump Administration Considering Adding Currency Rules to Nafta, Sources Say (Dow Jones)


We invite you to add your charity or supporting organizations' news stories and coming events to PVAngels so we can share them with the world. Do it now!

CHARITY ALERT Upcoming Free Dental Clinic for Locals in Sayulita Seeking Donations

The clinic, staffed by a volunteer group from Dental Avant Garde in Puerto Vallarta, and with the support of local businesses, will take place June 3rd and 4th in the Ejido building in Sayulita.

Please consider making a product donation.

See more info here

Meet the Charities

Community Services

Environmental

Animals & Wildlife

Health Care

Youth & Family

Education

Culture & Recreation

Special Interests

How You Can Help

Use Your Powers for Good

Add Your Favorite Charity

Save a Life - Give Blood

 

Partners for Change

Meet the Partners

Become a Partner for Change

Stay Connected

Find PVAngels on Facebook Follow PVAngels on Twitter Sign up PVAngels Newsletter RSS Feeds on PVAngels


Resources

About PVAngels

Add Your Charity

Add Your News & Events

Locate Yourself on Our Maps

Jobs - Join PVAngels Team

About Puerto Vallarta

Puerto Vallarta Local News

Local Event Calendar

Puerto Vallarta Videos

Puerto Vallarta Photos

Historic Puerto Vallarta

Local Area Maps

Important Phone Numbers

Craig's List in Puerto Vallarta

News Around Mexico

Mexico Issues & Opinions

Mexico Business News

Mexico Evironmental News

Lifestyle & Entertainment

Mexico Travel & Outdoors

Science & Technology News

Mexico News & Travel Videos


FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance a more in-depth understanding of critical issues facing the world. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 USC Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information click here. If you wish to use copyrighted material from this site for purposes that go beyond 'fair use', you must obtain permission from the copyright owner.

m3 • local actions from global awareness